FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/11/059441 [Registered on: 02/11/2023] Trial Registered Prospectively
Last Modified On: 24/08/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of Gomutra haritaki on Diabetes mellitus type 2 
Scientific Title of Study   A clinical study to evaluate the efficacy of Gomutra haritaki yog in the management of prameha(Madhumeha)W.S.R. Diabete mellitus type 2 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Seeta Rajoria  
Designation  Associate professor & PhD Scholar 
Affiliation  Madan Mohan Malviya Govt. Ayurved College Udaipur 
Address  P.G. Dept. of Kayachikitsa Madan Mohan Malviya Govt. Ayurved College Udaipur Udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  9414605849  
Fax    
Email  sitarajoria29@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Brahmanand Sharma 
Designation  Associate Professor & guide 
Affiliation  Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur 
Address  P.G. Dept. of Kayachikitsa Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved University,Jodhpur
P.G. Dept. of Kayachikitsa Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved University,Jodhpur
Jodhpur
RAJASTHAN
324002
India 
Phone  7976964483  
Fax    
Email  bkmudgal9@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Brahmanand sharma 
Designation  Associate professor & guide 
Affiliation  Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur 
Address  P.G. Dept. of Kayachikitsa Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur
P.G. Dept. of Kayachikitsa Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur
Jodhpur
RAJASTHAN
324002
India 
Phone  7976964483  
Fax    
Email  bkmudgal9@gmail.com  
 
Source of Monetary or Material Support  
Madan Mohan Malviya Govt Ayurved College Udaipur 
 
Primary Sponsor  
Name  Madan Mohan Malviya Govt Ayurved College Udaipur 
Address  Madan Mohan Malviya Govt. Ayurved College, Radaji Circle Ambamata, Udaipur 313001  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrBrhmanand Sharma  Madan Mohan Malviya Govt. Ayurved College Udaipur  P.G. Dept. of Kayachikitsa Madan Mohan Malviya Govt. Ayurved College Udaipur Udaipur RAJASTHAN Udaipur RAJASTHAN
Udaipur
RAJASTHAN 
7976964483

bkmudgal9@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr. Sarvepalli Radhakrishnan Rujasthan Ayurved Uniersity, Jodhpur Post Graduate Institute of Ayurved Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: PRAMEHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: GomutraSadhitaHaritakiYoga, Reference: chakradat , Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmLifestyle--Dinacarya: , Ritucarya: , Acara Rasayana:, Other:, Pathya/Apathya:yes, Pathya:yava,sarshapa tail,tikta kashaya pradhana dravyas for 90 days , Apathya:madhura,amla,lavana rasa pradhana dravyas for 90 days
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. The patients having clinical sign & symptoms of the Prameha (Madhumeh) & willing for
trial.
2. The patients who ages in between 25 – 70 years will be selected
3.international diagnosis criteria for diabetes (WHO)
(A) Patient having F.B.S. level >125 mg/dl <250 mg/dl (6.9 mmol/lit.)
(B) P.P.B.S. level >180 mg/dl to <350 mg/dl (10 mmol/lit.) will be selected for the trial
4. Either sex of different socio-economic groups. 
 
ExclusionCriteria 
Details  1. IDDM patients
2. Gestational diabetes.
3. Diabetes Mellitus produced due to other illnesses like Acromegaly, Cushing’s syndrome,
pancreatic disorders etc.
4. Acute complications Diabetic Keto-acidosis & hyperglycemic hyperosmolar coma.
5. Pregnant & Lactating Mother.
6. History of severe unstable angina, MI, CVA, Renal failure 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Symptoms like
Polyurea, Turbidity, burning sensation in palm and sole, polydipsia, fatigue, general weakness, polyphagia, sugar in the urine, and cramps will be analyzed
 
3 months 
 
Secondary Outcome  
Outcome  TimePoints 
fasting blood sugar & post prandial blood sugar will be analyzed  1 month & 2 months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   10/11/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a parallel group study to evaluate the efficacy of  gomutra haritaki in the management of diabetes mellitus type 2.In this study,group A,50 patients will be administered with gomutra haritaki, 5 gm, od for the duration of 3 months.And group B,50 patients will be advised to follow pathya-apathya of prameha for 3 months 
Close